PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsEiger Biopharmaceuticals
Eiger Biopharmaceuticals(EIGR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ZokinvyLonafarnib2022-07-182023-2024
Progeria
,
Laminopathies
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonafarnib
chronic hepatitis
,
progeria
,
chronic hepatitis d
,
hepatitis d
,
hepatitis b
,
laminopathies
Alfacalcidol
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis b
,
neoplasm metastasis
,
hyperparathyroidism
,
secondary hyperparathyroidism
Avexitide
hypoglycemia
,
congenital hyperinsulinism
,
nesidioblastosis
Bevifimod
healthy volunteers/patients
,
drug interactions
,
myeloid leukemia acute
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
arthritis
,
gouty arthritis
,
hematologic neoplasms
,
graft vs host disease
,
non-small-cell lung carcinoma
,
lung neoplasms
,
deglutition disorders
,
myelodysplastic syndromes
,
ear diseases
,
meniere disease
,
labyrinth diseases
,
labyrinthitis
,
cytokine release syndrome
,
follicular lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
stomatitis
,
neoplasms
,
leukemia
,
juvenile arthritis
,
mucositis
,
head and neck neoplasms
,
mucocutaneous lymph node syndrome
,
multiple myeloma
,
adult-onset still's disease
,
lymphoma
,
covid-19
,
cataract
,
infections
,
sars-cov-2
,
squamous cell carcinoma
,
squamous cell neoplasms
,
xerostomia
,
laryngeal diseases
,
oral ulcer
,
respiratory signs and symptoms
,
hemophilia a
,
hemophilia b
,
blood coagulation disorders
,
coagulation protein disorders
,
fever
,
hereditary autoinflammatory diseases
,
familial mediterranean fever
,
brucellosis
,
hematologic diseases
,
inborn genetic diseases
,
hemorrhagic disorders
Clemizole
hepatitis c
,
hepatitis
,
hepatitis a
Nepidermin
venous thromboembolism
,
thromboembolism
Ubenimex
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
lymphedema
Fendrix
liver diseases
,
end stage liver disease
,
liver failure
,
hepatocellular carcinoma
,
liver neoplasms
,
virus diseases
,
bacterial infections
,
whooping cough
,
tetanus
,
diphtheria
,
poliomyelitis
,
haemophilus infections
,
infections
,
coinfection
,
uterine cervical neoplasms
,
chronic hepatitis d
,
hepatitis d
,
chronic hepatitis c
,
liver cirrhosis
,
fibrosis
,
neisseria meningitidis
,
pneumococcal infections
,
condylomata acuminata
,
human influenza
,
haemophilus influenzae type b
,
herpesviridae infections
,
herpes zoster
,
mumps
,
measles
,
chickenpox
,
rubella
,
hepatitis b
,
hepatitis
,
hepatitis a
,
chronic hepatitis b
,
hiv infections
,
hepatitis c
,
chronic hepatitis
,
cardiovascular diseases
,
hiv
,
communicable diseases
,
chemical and drug induced liver injury
Ebp921
hepatitis d
,
hepatitis
,
hepatitis a
Mevalotin
rheumatoid arthritis
,
arthritis
,
hepatitis c
,
healthy volunteers/patients
,
mucocutaneous lymph node syndrome
,
dyslipidemias
,
liver diseases
,
hypercholesterolemia
,
chronic renal insufficiency
,
kidney diseases
,
infections
,
acute coronary syndrome
Exendin9
hypoglycemia
,
congenital hyperinsulinism
,
nesidioblastosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use